Abstract |
This study evaluated the safety and efficacy of the immunostimulatory agent OM-85 BV in 112 male car-factory workers who were highly susceptible to acute respiratory tract infections (ARTIs), each having experienced > or = 4 ARTIs during 1999. From January to March 2000, each worker received one capsule of OM-85 BV (7 mg) per day for 10 consecutive days each month. The patients were followed for a further 9 months. Mean number of ARTIs decreased from 8.2 +/- 2.1 per worker in 1999 to 5.3 +/- 2.9 in 2000; i.e. a difference of -2.9 (95% confidence intervals, -3.5 to -2.4). Similar effects were observed in men who had different job roles, and no adverse events were reported during drug administration. We concluded that OM-85 BV appears to be safe and effective in reducing the incidence of ARTIs in susceptible workers, although further double-blind, placebo-controlled clinical trials are required.
|
Authors | M A Carmona-Ramírez, V Alvárez-Gómez, A Berber |
Journal | The Journal of international medical research
(J Int Med Res)
2002 May-Jun
Vol. 30
Issue 3
Pg. 325-9
ISSN: 0300-0605 [Print] England |
PMID | 12166352
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adjuvants, Immunologic
- Broncho-Vaxom
- Cell Extracts
- Interferon Inducers
|
Topics |
- Adjuvants, Immunologic
(therapeutic use)
- Adult
- Bacteria
- Cell Extracts
- Humans
- Interferon Inducers
(therapeutic use)
- Male
- Middle Aged
- Occupational Diseases
(prevention & control)
- Prospective Studies
- Respiratory Tract Infections
(prevention & control)
|